The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2020

Filed:

Aug. 27, 2015
Applicants:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambrige, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Aviv Regev, Cambridge, MA (US);

Vijay Kuchroo, Newton, MA (US);

Hongkun Park, Lexington, MA (US);

Nir Yosef, Richmond, CA (US);

Alexander K. Shalek, Cambridge, MA (US);

Jellert Gaublomme, Cambridge, MA (US);

Nicole C. Joller, Brookline, MA (US);

Chuan Wu, Boston, MA (US);

Ana Carrizosa Anderson, Brookline, MA (US);

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/071 (2010.01); C12N 5/00 (2006.01); C12N 5/02 (2006.01); C07H 21/04 (2006.01); C12N 5/0783 (2010.01); C12Q 1/6881 (2018.01); A61K 31/12 (2006.01); A61K 31/198 (2006.01); A61K 31/37 (2006.01); A61K 31/4745 (2006.01); A61K 31/66 (2006.01); A61K 31/661 (2006.01); A61K 31/7076 (2006.01); A61K 31/7088 (2006.01); A61K 31/739 (2006.01); A61K 33/00 (2006.01); A61K 33/06 (2006.01); A61K 33/24 (2019.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/36 (2006.01); A61K 38/48 (2006.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01); G01N 33/569 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0636 (2013.01); A61K 31/12 (2013.01); A61K 31/198 (2013.01); A61K 31/37 (2013.01); A61K 31/4745 (2013.01); A61K 31/66 (2013.01); A61K 31/661 (2013.01); A61K 31/7076 (2013.01); A61K 31/7088 (2013.01); A61K 31/739 (2013.01); A61K 33/00 (2013.01); A61K 33/06 (2013.01); A61K 33/24 (2013.01); A61K 38/1767 (2013.01); A61K 38/1866 (2013.01); A61K 38/191 (2013.01); A61K 38/363 (2013.01); A61K 38/4866 (2013.01); C07K 16/28 (2013.01); C12N 5/0637 (2013.01); C12N 15/113 (2013.01); C12Q 1/6881 (2013.01); G01N 33/56972 (2013.01); A61K 48/00 (2013.01); C07K 2317/76 (2013.01); C12N 2310/14 (2013.01); C12N 2320/30 (2013.01); C12N 2501/15 (2013.01); C12N 2501/2301 (2013.01); C12N 2501/2306 (2013.01); C12N 2501/2323 (2013.01); C12N 2501/25 (2013.01); C12N 2501/90 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); C12Y 304/21069 (2013.01); G01N 2570/00 (2013.01); G01N 2800/56 (2013.01);
Abstract

This invention relates generally to compositions and methods for identifying the regulatory network that modulates, controls or otherwise influences T cell balance, for example, Th17 cell differentiation, maintenance and/or function, as well compositions and methods for exploiting the regulatory network that modulates, controls or otherwise influences T cell balance in a variety of therapeutic and/or diagnostic indications. This invention also relates generally to identifying and exploiting target genes and/or target gene products that modulate, control or otherwise influence T cell balance in a variety of therapeutic and/or diagnostic indications.


Find Patent Forward Citations

Loading…